Your fact-checks will appear here
United States federal government agency that explores complementary and alternative medicine
Available reporting on “GaraHerb” is dominated by manufacturer sites and a handful of review pages; these claim few side effects and a natural formulation but independent safety data, ingredient lists...
Clinical evidence that honey plus cinnamon improves memory in humans is very limited: systematic reviews find many animal and cell studies showing potential cognitive benefits for cinnamon and honey, ...
Consumers seeking to verify whether a dietary supplement marketed for blood‑sugar control actually works should treat marketing claims skeptically and demand randomized controlled trial (RCT)–level ev...
Clinical and preclinical reviews show honey and cinnamon have biological effects that could protect neurons and modestly boost learning or short-term memory in some studies; for example, a 2025 Nutrie...
The claim that specific cancer research programs were “reduced or eliminated under Trump’s budget” is rooted in multiple reporting threads: a proposed 2026 federal budget that would cut the NIH by rou...
Available product pages for GaraHerb claim the supplement is “natural” and “has minimal side effects,” but independent regulatory and clinical sources about key ingredients—particularly Garcinia cambo...
Manufacturers of proprietary “Alzheimer’s” supplements commonly include ingredients such as omega‑3 fatty acids (DHA/EPA), B‑vitamins (B6, B12, folate), vitamin E, curcumin, ginkgo biloba, coenzyme Q1...
Consumer-facing reviews and marketing materials for “neuroprotective” supplements often overstate human benefit while leaning on preclinical biology, and independent testing plus regulatory guidance w...
Large, well-designed clinical trials have mostly failed to show that single over‑the‑counter supplements prevent dementia or reliably improve memory, though a few exceptions and promising smaller stud...
Public-facing GaraHerb marketing claims the product is “natural” and “minimal side effects,” but independent safety authorities and medical reviews for ingredients commonly found in such supplements —...
Herbal ingredients commonly found in "Memory Blast"–style supplements — notably Bacopa monnieri and Ginkgo biloba — have mixed evidence on benefits and known safety signals: randomized trials and syst...
Herbal supplements commonly interact with prescription drugs that are metabolized by CYP enzymes, anticoagulants, sedatives and drugs with a narrow therapeutic index — examples cited in reviews and cl...
There are no peer‑reviewed studies or authoritative case reports in the provided reporting that document specific drug interactions or formal contraindications for the commercial product GaraHerb itse...
ClinicalTrials.gov is the primary public registry where ongoing and completed clinical trials of dietary supplements are listed and searchable, complemented by domain-specific resources such as PubMed...
Lipoless-style products—ranging in reporting from a prescription injectable (tirzepatide marketed as “Lipoless” in Paraguay) to over‑the‑counter weight‑loss supplements—pose two clear interaction risk...
Garaherb’s public materials present it as a plant‑based male enhancement supplement without a full, clearly published ingredient list on the product site , and independent reviews emphasize it is a di...
Randomized trials testing cinnamon, chromium, and alpha‑lipoic acid (ALA) for type 2 diabetes have produced uneven, often conflicting results: cinnamon trials are small and inconsistent with some posi...
The available reporting links turmeric and banana to general health benefits—turmeric (curcumin) is described repeatedly as an anti-inflammatory antioxidant, and bananas are noted for potassium, fiber...
Regulators and independent testers recorded multiple high‑profile warnings, recalls and quality‑control studies (2023–2025) showing memory and brain‑health supplements have been mislabelled, adulterat...
Major medical bodies have not broadly endorsed specific over‑the‑counter supplements as proven treatments for Alzheimer’s; the Alzheimer’s Association in 2022 reported a positive COSMOS‑Mind trial res...